{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:52:55Z","timestamp":1787032375530,"version":"build-2736575974"},"reference-count":308,"publisher":"Harborside Press, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin\u2019s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.<\/jats:p>","DOI":"10.6004\/jnccn.2019.0008","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T15:25:53Z","timestamp":1550676353000},"page":"171-189","source":"Crossref","is-referenced-by-count":55,"title":["AIDS-Related Kaposi Sarcoma, Version 2.2019"],"prefix":"10.6004","volume":"17","author":[{"given":"Erin","family":"Reid","sequence":"first","affiliation":[{"name":"1UC San Diego Moores Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Suneja","sequence":"additional","affiliation":[{"name":"2Duke Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Ambinder","sequence":"additional","affiliation":[{"name":"3The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ard","sequence":"additional","affiliation":[{"name":"4Massachusetts General Hospital Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Baiocchi","sequence":"additional","affiliation":[{"name":"5The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Barta","sequence":"additional","affiliation":[{"name":"6Fox Chase Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evie","family":"Carchman","sequence":"additional","affiliation":[{"name":"7University of Wisconsin Carbone Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cohen","sequence":"additional","affiliation":[{"name":"8Huntsman Cancer Institute at the University of Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana V.","family":"Crysler","sequence":"additional","affiliation":[{"name":"9University of Michigan Rogel Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Gupta","sequence":"additional","affiliation":[{"name":"10Stanford Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Gustafson","sequence":"additional","affiliation":[{"name":"11Robert H. Lurie Comprehensive Cancer Center of Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Hall","sequence":"additional","affiliation":[{"name":"2Duke Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Johung","sequence":"additional","affiliation":[{"name":"12Yale Cancer Center\/Smilow Cancer Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Klopp","sequence":"additional","affiliation":[{"name":"13The University of Texas MD Anderson Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann S.","family":"LaCasce","sequence":"additional","affiliation":[{"name":"14Dana-Farber\/Brigham and Women's Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Lin","sequence":"additional","affiliation":[{"name":"15Fred & Pamela Buffett Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitkumar","family":"Mehta","sequence":"additional","affiliation":[{"name":"16University of Alabama at Birmingham Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj P.","family":"Menon","sequence":"additional","affiliation":[{"name":"17Fred Hutchinson Cancer Research Center\/Seattle Cancer Care Alliance;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Morgan","sequence":"additional","affiliation":[{"name":"18Vanderbilt-Ingram Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Nathwani","sequence":"additional","affiliation":[{"name":"19City of Hope National Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Noy","sequence":"additional","affiliation":[{"name":"20Memorial Sloan Kettering Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ratner","sequence":"additional","affiliation":[{"name":"21Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Rizza","sequence":"additional","affiliation":[{"name":"22Mayo Clinic Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Rudek","sequence":"additional","affiliation":[{"name":"3The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Sanchez","sequence":"additional","affiliation":[{"name":"23Moffitt Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Taylor","sequence":"additional","affiliation":[{"name":"24HIV + Aging Research Project - Palm Springs;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"25Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ching J.","family":"Wang","sequence":"additional","affiliation":[{"name":"26UCSF Helen Diller Family Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Yendamuri","sequence":"additional","affiliation":[{"name":"27Roswell Park Comprehensive Cancer Center; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CGC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Freedman-Cass","sequence":"additional","affiliation":[{"name":"28National Comprehensive Cancer Network."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"ref1211","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2147\/CCID.S94320","article-title":"Chronic radiation-induced dermatitis: challenges and solutions","volume":"9","author":"Spa\u0142ek","year":"2016","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref1641","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref1831","article-title":"Care Continuum HIV HIV gov Available at https www hiv gov federal response policies issues hiv aids care continuum Accessed September","volume":"26","year":"2017"},{"key":"ref1771","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10461-015-1025-y","article-title":"Alcohol-related diagnoses and all-cause hospitalization among HIV-infected and uninfected patients: a longitudinal analysis of United States veterans from 1997 to 2011","volume":"20","author":"Rentsch","year":"2016","journal-title":"AIDS Behav"},{"key":"ref3021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1258\/0956462991914285","article-title":"A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi\u2019s sarcoma. Swiss HIV Cohort Study","volume":"10","author":"Opravil","year":"1999","journal-title":"Int J STD AIDS"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jnci\/89.4.301","article-title":"Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma treated with chemotherapy","volume":"89","author":"Sparano","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QAI.0000000000000862","article-title":"Accuracy of clinical suspicion and pathologic diagnosis of Kaposi sarcoma in east Africa","volume":"71","author":"Amerson","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1998.16.2.683","article-title":"Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi\u2019s sarcoma","volume":"16","author":"Stewart","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref1471","first-page":"17","article-title":"Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi\u2019s sarcoma: AIDS Clinical Trials Group Protocol 057","volume":"4","author":"Miles","year":"1998","journal-title":"Cytokines Cell Mol Ther"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/QAI.0000000000001394","article-title":"Association of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada","volume":"75","author":"Dubrow","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref1691","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jnci\/djp205","article-title":"Risk of human papillomavirus-associated cancers among persons with AIDS","volume":"101","author":"Chaturvedi","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref2901","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/annonc\/mdg461","article-title":"Paclitaxel for anthracycline-resistant AIDS-related Kaposi\u2019s sarcoma: clinical and angiogenic correlations","volume":"14","author":"Stebbing","year":"2003","journal-title":"Ann Oncol"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","article-title":"Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: a meta-analysis","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"key":"ref2001","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"ref2081","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi\u2019s sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N Engl J Med"},{"key":"ref2191","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ996","article-title":"Clinical features and outcomes of patients with symptomatic Kaposi sarcoma herpesvirus (KSHV)-associated inflammation: Prospective characterization of KSHV inflammatory cytokine syndrome (KICS)","volume":"62","author":"Polizzotto","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref1151","first-page":"2153","article-title":"Radiation therapy in the treatment of HIV-related Kaposi\u2019s sarcoma","volume":"33","author":"Donato","year":"2013","journal-title":"Anticancer Res"},{"key":"ref1611","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"ref2551","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/1097-0142(19930301)71:5<1722::AID-CNCR2820710503>3.0.CO;2-0","article-title":"Treatment of oral Kaposi sarcoma with intralesional vinblastine","volume":"71","author":"Epstein","year":"1993","journal-title":"Cancer"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ996","article-title":"Clinical features and outcomes of patients with symptomatic Kaposi sarcoma herpesvirus (KSHV)-associated inflammation: Prospective characterization of KSHV inflammatory cytokine syndrome (KICS)","volume":"62","author":"Polizzotto","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/QAD.0000000000000993","article-title":"Steroids are a risk factor for Kaposi\u2019s sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection","volume":"30","author":"Fern\u00e1ndez-S\u00e1nchez","year":"2016","journal-title":"AIDS"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/QAD.0b013e32832d080d","article-title":"The effect of HAART in 254 consecutive patients with AIDS-related Kaposi\u2019s sarcoma","volume":"23","author":"Bower","year":"2009","journal-title":"AIDS"},{"key":"ref3071","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.qai.0000194237.15831.23","article-title":"Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial","volume":"41","author":"Krown","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2641","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09546634.2015.1094177","article-title":"Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma","volume":"27","author":"Sen","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"ref1821","first-page":"E200","article-title":"Testing for human immunodeficiency virus among cancer survivors under age 65 in the United States","volume":"11","author":"Li","year":"2014","journal-title":"Prev Chronic Dis"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-3062.2007.00239.x","article-title":"Development of Kaposi\u2019s sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod","volume":"10","author":"Babel","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"ref1271","first-page":"051","article-title":"doxorubicin hydrochloride liposome injection for intravenous use Horsham PA Products LP Available at https www accessdata fda gov drugsatfda docs label lbl pdf Accessed November","volume":"21","author":"DOXIL","year":"2016"},{"key":"ref3011","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1200\/JCO.2012.48.6365","article-title":"Phase II trial of imatinib in AIDS-associated Kaposi\u2019s sarcoma: AIDS Malignancy Consortium Protocol 042","volume":"32","author":"Koon","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi\u2019s sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N Engl J Med"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00128071-200102020-00004","article-title":"Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi\u2019s sarcoma","volume":"2","author":"Bodsworth","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"ref1841","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/QAI.0000000000000578","article-title":"Benefits of a routine opt-out HIV testing and linkage to care program for previously diagnosed patients in publicly funded emergency departments in Houston, TX","volume":"69","author":"Flash","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/QAI.0b013e318251aedd","article-title":"A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa","volume":"60","author":"Mosam","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2381","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12981-017-0156-9","article-title":"Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma","volume":"14","author":"Volkow","year":"2017","journal-title":"AIDS Res Ther"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref1371","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1200\/JCO.1997.15.5.2118","article-title":"Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi\u2019s sarcoma with no prior exposure to cytotoxic therapy","volume":"15","author":"Schwartsmann","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref1521","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2000.18.13.2593","article-title":"Activity of thalidomide in AIDS-related Kaposi\u2019s sarcoma","volume":"18","author":"Little","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref2631","first-page":"E28","article-title":"Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients","volume":"95","author":"Vassallo","year":"2015","journal-title":"Cutis"},{"key":"ref451","first-page":"13","article-title":"Empiric antibiotic therapy for granulocytopenic cancer patients","volume":"80","author":"Schimpff","year":"1986","journal-title":"Am J Med"},{"key":"ref2691","first-page":"329","article-title":"Radiotherapy in the management of Kaposi\u2019s sarcoma","volume":"29","author":"Becker","year":"2006","journal-title":"Onkologie"},{"key":"ref2721","first-page":"2153","article-title":"Radiation therapy in the treatment of HIV-related Kaposi\u2019s sarcoma","volume":"33","author":"Donato","year":"2013","journal-title":"Anticancer Res"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D302V86610","article-title":"Off-label indications for imiquimod","volume":"15","author":"Ganjian","year":"2009","journal-title":"Dermatol Online J"},{"key":"ref2531","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0956462413517494","article-title":"Isolated penile Kaposi\u2019s sarcoma in a HIV-positive patient stable on treatment for three years","volume":"25","author":"Lebari","year":"2014","journal-title":"Int J STD AIDS"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators","volume":"280","author":"Detels","year":"1998","journal-title":"JAMA"},{"key":"ref2741","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1200\/JCO.1987.5.1.107","article-title":"The impact of palliative irradiation on the management of patients with acquired immune deficiency syndrome","volume":"5","author":"Nobler","year":"1987","journal-title":"J Clin Oncol"},{"key":"ref2501","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1258\/ijsa.2012.012074","article-title":"Topical imiquimod 5% as a treatment for localized genital Kaposi\u2019s sarcoma in an HIV-negative man: a case report","volume":"23","author":"Fairley","year":"2012","journal-title":"Int J STD AIDS"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/QAD.0000000000000682","article-title":"Epidemiology of Kaposi\u2019s sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy","volume":"29","author":"Labo","year":"2015","journal-title":"AIDS"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi\u2019s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-4632.2006.02829.x","article-title":"Limited extent AIDS-related cutaneous Kaposi\u2019s sarcoma responsive to imiquimod 5% cream","volume":"45","author":"Rosen","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref2801","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1998.16.2.683","article-title":"Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi\u2019s sarcoma","volume":"16","author":"Stewart","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1200\/JCO.2005.14.597","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposi\u2019s sarcoma","volume":"23","author":"Bower","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref1481","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042560-199604010-00008","article-title":"A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi\u2019s sarcoma","volume":"11","author":"Fischl","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref2171","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PGP.0b013e31823f8463","article-title":"Bartonella quintana-induced vulval bacillary angiomatosis","volume":"31","author":"Ramdial","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"ref2491","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3315\/jdcr.2012.1099","article-title":"Efficacy of 5% imiquimod cream in a patient with classic Kaposi sarcoma","volume":"6","author":"G\u00fcnd\u00fcz","year":"2012","journal-title":"J Dermatol Case Rep"},{"key":"ref2881","first-page":"CD003256","article-title":"Treatment of severe or progressive Kaposi\u2019s sarcoma in HIV-infected adults","author":"Gbabe","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref1141","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0360-3016(91)90051-5","article-title":"Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi\u2019s sarcoma","volume":"20","author":"Cooper","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref3031","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1998.16.5.1736","article-title":"Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi\u2019s sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study","volume":"16","author":"Shepherd","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study","volume":"4","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Lancet HIV"},{"key":"ref3111","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1200\/JCO.2000.18.7.1550","article-title":"Vinorelbine is an effective and safe drug for AIDS-related Kaposi\u2019s sarcoma: results of a phase II study","volume":"18","author":"Nasti","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"ref3041","first-page":"17","article-title":"Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi\u2019s sarcoma: AIDS Clinical Trials Group Protocol 057","volume":"4","author":"Miles","year":"1998","journal-title":"Cytokines Cell Mol Ther"},{"key":"ref2221","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/RMR.0000000000000031","article-title":"Imaging of the brain in patients with human immunodeficiency virus infection","volume":"23","author":"Gottumukkala","year":"2014","journal-title":"Top Magn Reson Imaging"},{"key":"ref2251","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(03)14366-8","article-title":"Whole-body positron emission tomography in patients with HIV-1 infection","volume":"362","author":"Scharko","year":"2003","journal-title":"Lancet"},{"key":"ref2821","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"},{"key":"ref01","article-title":"US HIV gov Available at https www hiv gov hiv basics overview data and trends statistics Accessed","volume":"31","author":"August","year":"2018","journal-title":"Statistics"},{"key":"ref3121","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJMe058018","article-title":"Immunosuppressive drugs and the risk of cancer after organ transplantation","volume":"352","author":"Dantal","year":"2005","journal-title":"N Engl J Med"},{"key":"ref1601","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators","volume":"280","author":"Detels","year":"1998","journal-title":"JAMA"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.bmt.1701610","article-title":"Neutropenic infections in 100 patients with non-Hodgkin\u2019s lymphoma or Hodgkin\u2019s disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option","volume":"23","author":"Seropian","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/cis933","article-title":"Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study","volume":"56","author":"Helleberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/1097-0142(19891215)64:12<2424::AID-CNCR2820641205>3.0.CO;2-X","article-title":"Oral Kaposi\u2019s sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine","volume":"64","author":"Epstein","year":"1989","journal-title":"Cancer"},{"key":"ref2271","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi\u2019s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"ref1221","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi\u2019s sarcoma: results of a randomized phase III clinical trial","volume":"16","author":"Northfelt","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref1661","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.2011.396","article-title":"Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007","volume":"305","author":"Shiels","year":"2011","journal-title":"JAMA"},{"key":"ref1861","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival","volume":"360","author":"Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1258\/ijsa.2012.012074","article-title":"Topical imiquimod 5% as a treatment for localized genital Kaposi\u2019s sarcoma in an HIV-negative man: a case report","volume":"23","author":"Fairley","year":"2012","journal-title":"Int J STD AIDS"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"2138259","DOI":"10.1155\/2016\/2138259","article-title":"Risk of cancer among commercially insured HIV-infected adults on antiretroviral therapy","volume":"2016","author":"Lee","year":"2016","journal-title":"J Cancer Epidemiol"},{"key":"ref3051","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042560-199604010-00008","article-title":"A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi\u2019s sarcoma","volume":"11","author":"Fischl","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref1321","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1200\/JCO.1997.15.2.653","article-title":"Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi\u2019s sarcoma after failure of standard chemotherapy","volume":"15","author":"Northfelt","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2249.1992.tb06965.x","article-title":"Predictors of infection in chronic lymphocytic leukaemia (CLL)","volume":"89","author":"Griffiths","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1468-1293.2011.00955.x","article-title":"Clinical outcomes of HIV-infected patients with Kaposi\u2019s sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda","volume":"13","author":"Asiimwe","year":"2012","journal-title":"HIV Med"},{"key":"ref1181","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2008.03.009","article-title":"Hypofractionated radiation therapy in the treatment of epidemic Kaposi sarcoma--a prospective randomized trial","volume":"88","author":"Singh","year":"2008","journal-title":"Radiother Oncol"},{"key":"ref1701","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study","volume":"282","author":"Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"ref1781","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.qai.0000151079.33935.79","article-title":"Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs","volume":"39","author":"Marks","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref1651","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/QAD.0000000000000163","article-title":"Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States","volume":"28","author":"Robbins","year":"2014","journal-title":"AIDS"},{"key":"ref2291","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1468-1293.2011.00955.x","article-title":"Clinical outcomes of HIV-infected patients with Kaposi\u2019s sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda","volume":"13","author":"Asiimwe","year":"2012","journal-title":"HIV Med"},{"key":"ref2891","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1200\/JCO.1997.15.2.653","article-title":"Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi\u2019s sarcoma after failure of standard chemotherapy","volume":"15","author":"Northfelt","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref1391","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1200\/JCO.2002.12.038","article-title":"Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi\u2019s sarcoma: an AIDS Clinical Trials Group clinical study","volume":"20","author":"Evans","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.qai.0000151079.33935.79","article-title":"Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs","volume":"39","author":"Marks","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2751","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2008.03.009","article-title":"Hypofractionated radiation therapy in the treatment of epidemic Kaposi sarcoma--a prospective randomized trial","volume":"88","author":"Singh","year":"2008","journal-title":"Radiother Oncol"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00002030-200005260-00010","article-title":"Long-term efficacy on Kaposi\u2019s sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d\u2019information et de soins de l\u2019immunod\u00e9ficience humaine","volume":"14","author":"Dupont","year":"2000","journal-title":"AIDS"},{"key":"ref2701","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1468-3083.2007.02405.x","article-title":"Radiotherapy of classic and human immunodeficiency virus-related Kaposi\u2019s sarcoma: results in 1482 lesions","volume":"22","author":"Caccialanza","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2301","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/QAD.0b013e32832d080d","article-title":"The effect of HAART in 254 consecutive patients with AIDS-related Kaposi\u2019s sarcoma","volume":"23","author":"Bower","year":"2009","journal-title":"AIDS"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/QAD.0b013e3282ff6275","article-title":"Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response","volume":"22","author":"Nguyen","year":"2008","journal-title":"AIDS"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0964-1955(95)00009-7","article-title":"Role of intralesional vinblastine administration in treatment of intraoral Kaposi\u2019s sarcoma in AIDS","volume":"31","author":"Flaitz","year":"1995","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"ref1061","first-page":"E28","article-title":"Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients","volume":"95","author":"Vassallo","year":"2015","journal-title":"Cutis"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00126334-200208150-00003","article-title":"Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival","volume":"30","author":"G\u00e9rard","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2831","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jnci\/djp205","article-title":"Risk of human papillomavirus-associated cancers among persons with AIDS","volume":"101","author":"Chaturvedi","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref2811","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref1921","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study","volume":"282","author":"Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"ref1731","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s10461-008-9449-2","article-title":"Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation","volume":"14","author":"Tesoriero","year":"2010","journal-title":"AIDS Behav"},{"key":"ref1621","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"ref1751","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1200\/JCO.2006.05.7984","article-title":"Hepatocellular carcinoma and non-Hodgkin\u2019s lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse","volume":"24","author":"McGinnis","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref2841","first-page":"051","article-title":"doxorubicin hydrochloride liposome injection for intravenous use Horsham PA Products LP Available at https www accessdata fda gov drugsatfda docs label lbl pdf Accessed November","volume":"21","author":"DOXIL","year":"2016"},{"key":"ref1761","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","article-title":"Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: a meta-analysis","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"key":"ref1941","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/infdis\/jiv235","article-title":"Mortality risk after AIDS-defining opportunistic illness among HIV-infected persons\u2013San Francisco, 1981-2012","volume":"212","author":"Djawe","year":"2015","journal-title":"J Infect Dis"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3346\/jkms.2012.27.12.1468","article-title":"Risk factors for febrile neutropenia during chemotherapy for HIV-related lymphoma","volume":"27","author":"Park","year":"2012","journal-title":"J Korean Med Sci"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/QAD.0b013e3282f4f223","article-title":"Life-threatening exacerbation of Kaposi\u2019s sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome","volume":"22","author":"Volkow","year":"2008","journal-title":"AIDS"},{"key":"ref1671","doi-asserted-by":"crossref","first-page":"DJU503","DOI":"10.1093\/jnci\/dju503","article-title":"Excess cancers among HIV-infected people in the United States","volume":"107","author":"Robbins","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"},{"key":"ref2971","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000292356","article-title":"Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi\u2019s sarcoma in western Kenya","volume":"78","author":"Strother","year":"2010","journal-title":"Oncology"},{"key":"ref2161","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2325957414521497","article-title":"Bacillary angiomatosis masquerading as Kaposi\u2019s sarcoma in East Africa","volume":"14","author":"Forrestel","year":"2015","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref2351","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1200\/JCO.2005.14.597","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposi\u2019s sarcoma","volume":"23","author":"Bower","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref2651","first-page":"E35","article-title":"Classic solitary Kaposi sarcoma of the foot in an immunocompetent patient: a case report","volume":"28","author":"Schmidt","year":"2016","journal-title":"Wounds"},{"key":"ref2771","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s10029-006-0150-y","article-title":"Radiation responses in skin and connective tissues: effect on wound healing and surgical outcome","volume":"10","author":"Wang","year":"2006","journal-title":"Hernia"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4103\/0253-7613.161249","article-title":"Imiquimod - Its role in the treatment of cutaneous malignancies","volume":"47","author":"Bubna","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"ref2211","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11904-012-0140-x","article-title":"Pathogenesis of HIV and the lung","volume":"10","author":"Gingo","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","article-title":"Biphasic pattern of bacterial infection in multiple myeloma","volume":"96","author":"Savage","year":"1982","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDS-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/modpathol.2008.15","article-title":"Classic Kaposi Sarcoma in the United States over the last two decades: a clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi Sarcoma","volume":"21","author":"Hiatt","year":"2008","journal-title":"Mod Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"ref1581","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"Goedert","year":"1998","journal-title":"Lancet"},{"key":"ref2151","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QAI.0000000000000862","article-title":"Accuracy of clinical suspicion and pathologic diagnosis of Kaposi sarcoma in east Africa","volume":"71","author":"Amerson","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2671","first-page":"107","article-title":"A rare case of Kaposi\u2019s sarcoma; hand localization","volume":"22","author":"Ozbek","year":"1990","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2325957414521497","article-title":"Bacillary angiomatosis masquerading as Kaposi\u2019s sarcoma in East Africa","volume":"14","author":"Forrestel","year":"2015","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref1421","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.3747\/co.22.2635","article-title":"Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control: a case report and literature review","volume":"22","author":"Cao","year":"2015","journal-title":"Curr Oncol"},{"key":"ref261","article-title":"Care Continuum HIV HIV gov Available at https www hiv gov federal response policies issues hiv aids care continuum Accessed September","volume":"26","year":"2017"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12981-017-0156-9","article-title":"Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma","volume":"14","author":"Volkow","year":"2017","journal-title":"AIDS Res Ther"},{"key":"ref2421","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00126334-199911010-00004","article-title":"Treatment of AIDS-related cutaneous Kaposi\u2019s sarcoma with topical alitretinoin (9-cis-retinoic acid) gel","volume":"22","author":"Walmsley","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09546634.2015.1094177","article-title":"Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma","volume":"27","author":"Sen","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11904-012-0140-x","article-title":"Pathogenesis of HIV and the lung","volume":"10","author":"Gingo","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/cncr.20688","article-title":"CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer","volume":"101","author":"Borg","year":"2004","journal-title":"Cancer"},{"key":"ref2711","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0360-3016(91)90051-5","article-title":"Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi\u2019s sarcoma","volume":"20","author":"Cooper","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref2861","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(95)92654-2","article-title":"Treatment of HIV-associated Kaposi\u2019s sarcoma with paclitaxel","volume":"346","author":"Saville","year":"1995","journal-title":"Lancet"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1368-8375(01)00100-2","article-title":"Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi\u2019s sarcoma. A double blind, randomized clinical trial","volume":"38","author":"Ram\u00edrez-Amador","year":"2002","journal-title":"Oral Oncol"},{"key":"ref2241","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.aids.0000222070.52996.76","article-title":"Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation","volume":"20","author":"Brust","year":"2006","journal-title":"AIDS"},{"key":"ref2031","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3346\/jkms.2012.27.12.1468","article-title":"Risk factors for febrile neutropenia during chemotherapy for HIV-related lymphoma","volume":"27","author":"Park","year":"2012","journal-title":"J Korean Med Sci"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0190-9622(97)70288-3","article-title":"Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi\u2019s sarcoma","volume":"36","author":"Smith","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"ref2591","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0278-2391(96)90637-0","article-title":"Intralesional vinblastine injections for the treatment of oral Kaposi\u2019s sarcoma: report of 10 patients with 2-year follow-up","volume":"54","author":"McCormick","year":"1996","journal-title":"J Oral Maxillofac Surg"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"440","DOI":"10.6004\/jnccn.2003.0038","article-title":"Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trials","volume":"1","author":"Dale","year":"2003","journal-title":"J Natl Compr Canc Netw"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/1097-0142(19930301)71:5<1722::AID-CNCR2820710503>3.0.CO;2-0","article-title":"Treatment of oral Kaposi sarcoma with intralesional vinblastine","volume":"71","author":"Epstein","year":"1993","journal-title":"Cancer"},{"key":"ref251","first-page":"E200","article-title":"Testing for human immunodeficiency virus among cancer survivors under age 65 in the United States","volume":"11","author":"Li","year":"2014","journal-title":"Prev Chronic Dis"},{"key":"ref1361","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2011.39.6853","article-title":"Phase II study of bevacizumab in patients with HIV-associated Kaposi\u2019s sarcoma receiving antiretroviral therapy","volume":"30","author":"Uldrick","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/QAD.0000000000000163","article-title":"Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States","volume":"28","author":"Robbins","year":"2014","journal-title":"AIDS"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0278-2391(96)90637-0","article-title":"Intralesional vinblastine injections for the treatment of oral Kaposi\u2019s sarcoma: report of 10 patients with 2-year follow-up","volume":"54","author":"McCormick","year":"1996","journal-title":"J Oral Maxillofac Surg"},{"key":"ref1951","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/cncr.20688","article-title":"CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer","volume":"101","author":"Borg","year":"2004","journal-title":"Cancer"},{"key":"ref1741","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/cis933","article-title":"Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study","volume":"56","author":"Helleberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s10029-006-0150-y","article-title":"Radiation responses in skin and connective tissues: effect on wound healing and surgical outcome","volume":"10","author":"Wang","year":"2006","journal-title":"Hernia"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/QAI.0000000000000578","article-title":"Benefits of a routine opt-out HIV testing and linkage to care program for previously diagnosed patients in publicly funded emergency departments in Houston, TX","volume":"69","author":"Flash","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2181","first-page":"163","article-title":"Cutaneous cryptococcosis simulating Kaposi\u2019s sarcoma in the acquired immunodeficiency syndrome","volume":"45","author":"Jones","year":"1990","journal-title":"Cutis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"Goedert","year":"1998","journal-title":"Lancet"},{"key":"ref1541","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1200\/JCO.2000.18.7.1550","article-title":"Vinorelbine is an effective and safe drug for AIDS-related Kaposi\u2019s sarcoma: results of a phase II study","volume":"18","author":"Nasti","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref2621","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0190-9622(97)70288-3","article-title":"Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi\u2019s sarcoma","volume":"36","author":"Smith","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S0950268812000325","article-title":"Epidemiology of classic and AIDS-related Kaposi\u2019s sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005","volume":"141","author":"Armstrong","year":"2013","journal-title":"Epidemiol Infect"},{"key":"ref2681","first-page":"80","article-title":"Excision of 1,674 classic Kaposi\u2019s sarcomas","volume":"40","author":"Weintraub","year":"2002","journal-title":"S Afr J Surg"},{"key":"ref1131","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1468-3083.2007.02405.x","article-title":"Radiotherapy of classic and human immunodeficiency virus-related Kaposi\u2019s sarcoma: results in 1482 lesions","volume":"22","author":"Caccialanza","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PGP.0b013e31823f8463","article-title":"Bartonella quintana-induced vulval bacillary angiomatosis","volume":"31","author":"Ramdial","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"ref1461","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1998.16.5.1736","article-title":"Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi\u2019s sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study","volume":"16","author":"Shepherd","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/aje\/kwm017","article-title":"The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS","volume":"165","author":"Hessol","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref1891","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00126334-200208150-00003","article-title":"Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival","volume":"30","author":"G\u00e9rard","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref1491","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/107999002753675712","article-title":"Efficacy of low-dose interferon with antiretroviral therapy in Kaposi\u2019s sarcoma: a randomized phase II AIDS clinical trials group study","volume":"22","author":"Krown","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-8140(97)00147-3","article-title":"Radiotherapy in the management of epidemic Kaposi\u2019s sarcoma: a retrospective study of 643 cases","volume":"46","author":"Kirova","year":"1998","journal-title":"Radiother Oncol"},{"key":"ref1291","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(95)92654-2","article-title":"Treatment of HIV-associated Kaposi\u2019s sarcoma with paclitaxel","volume":"346","author":"Saville","year":"1995","journal-title":"Lancet"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1200\/JCO.2006.05.7984","article-title":"Hepatocellular carcinoma and non-Hodgkin\u2019s lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse","volume":"24","author":"McGinnis","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3315\/jdcr.2012.1099","article-title":"Efficacy of 5% imiquimod cream in a patient with classic Kaposi sarcoma","volume":"6","author":"G\u00fcnd\u00fcz","year":"2012","journal-title":"J Dermatol Case Rep"},{"key":"ref3061","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/107999002753675712","article-title":"Efficacy of low-dose interferon with antiretroviral therapy in Kaposi\u2019s sarcoma: a randomized phase II AIDS clinical trials group study","volume":"22","author":"Krown","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0385-8146(00)00053-5","article-title":"Local treatment of AIDS-associated bulky Kaposi\u2019s sarcoma in the head and neck region","volume":"27","author":"Shimomura","year":"2000","journal-title":"Auris Nasus Larynx"},{"key":"ref3101","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1258\/0956462981921512","article-title":"Activity of thalidomide in AIDS-related Kaposi\u2019s sarcoma and correlation with HHV8 titre","volume":"9","author":"Fife","year":"1998","journal-title":"Int J STD AIDS"},{"key":"ref1401","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000292356","article-title":"Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi\u2019s sarcoma in western Kenya","volume":"78","author":"Strother","year":"2010","journal-title":"Oncology"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2007.11.005","article-title":"Imiquimod 5% cream for treatment of HIV-negative Kaposi\u2019s sarcoma skin lesions: A phase I to II, open-label trial in 17 patients","volume":"58","author":"C\u00e9lestin Schartz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref1111","first-page":"80","article-title":"Excision of 1,674 classic Kaposi\u2019s sarcomas","volume":"40","author":"Weintraub","year":"2002","journal-title":"S Afr J Surg"},{"key":"ref1531","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1258\/0956462981921512","article-title":"Activity of thalidomide in AIDS-related Kaposi\u2019s sarcoma and correlation with HHV8 titre","volume":"9","author":"Fife","year":"1998","journal-title":"Int J STD AIDS"},{"key":"ref2581","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/000348949610500405","article-title":"Intralesional vinblastine for treating AIDS-associated Kaposi\u2019s sarcoma of the oropharynx and larynx","volume":"105","author":"Friedman","year":"1996","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref2511","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2007.11.005","article-title":"Imiquimod 5% cream for treatment of HIV-negative Kaposi\u2019s sarcoma skin lesions: A phase I to II, open-label trial in 17 patients","volume":"58","author":"C\u00e9lestin Schartz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.aids.0000222070.52996.76","article-title":"Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation","volume":"20","author":"Brust","year":"2006","journal-title":"AIDS"},{"key":"ref1431","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1200\/JCO.2005.06.079","article-title":"Imatinib-induced regression of AIDS-related Kaposi\u2019s sarcoma","volume":"23","author":"Koon","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref151","first-page":"1993","article-title":"Increased incidence of cancer observed in HIV HCV coinfected patients versus HIV - monoinfected Available at https www ncbi nlm nih gov pubmed Accessed","volume":"14","author":"MeijideH","year":"2017","journal-title":"AIDS"},{"key":"ref2011","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1093\/cid\/ciu592","article-title":"Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies","volume":"59","author":"Morrison","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref1081","first-page":"E35","article-title":"Classic solitary Kaposi sarcoma of the foot in an immunocompetent patient: a case report","volume":"28","author":"Schmidt","year":"2016","journal-title":"Wounds"},{"key":"ref2851","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1998.16.3.1112","article-title":"Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi\u2019s sarcoma","volume":"16","author":"Welles","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1200\/JCO.2016.69.3812","article-title":"Pomalidomide for symptomatic Kaposi\u2019s sarcoma in people with and without HIV infection: a phase I\/II study","volume":"34","author":"Polizzotto","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref1121","first-page":"329","article-title":"Radiotherapy in the management of Kaposi\u2019s sarcoma","volume":"29","author":"Becker","year":"2006","journal-title":"Onkologie"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study","volume":"24","author":"Buchacz","year":"2010","journal-title":"AIDS"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.4076\/1757-1626-2-7092","article-title":"Kaposi\u2019s sarcoma responding to topical imiquimod 5% cream: a case report","volume":"2","author":"Benomar","year":"2009","journal-title":"Cases J"},{"key":"ref2541","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/1097-0142(19891215)64:12<2424::AID-CNCR2820641205>3.0.CO;2-X","article-title":"Oral Kaposi\u2019s sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine","volume":"64","author":"Epstein","year":"1989","journal-title":"Cancer"},{"key":"ref1571","article-title":"US HIV gov Available at https www hiv gov hiv basics overview data and trends statistics Accessed","volume":"31","author":"August","year":"2018","journal-title":"Statistics"},{"key":"ref2661","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2310\/7750.2011.10039","article-title":"Kaposi sarcoma of the penis in an HIV-negative patient","volume":"15","author":"Cecchi","year":"2011","journal-title":"J Cutan Med Surg"},{"key":"ref2431","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4103\/0253-7613.161249","article-title":"Imiquimod - Its role in the treatment of cutaneous malignancies","volume":"47","author":"Bubna","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"ref1311","first-page":"CD003256","article-title":"Treatment of severe or progressive Kaposi\u2019s sarcoma in HIV-infected adults","author":"Gbabe","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2481","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2230.2011.04278.x","article-title":"Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation","volume":"37","author":"Prinz Vavricka","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"ref2571","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0964-1955(95)00009-7","article-title":"Role of intralesional vinblastine administration in treatment of intraoral Kaposi\u2019s sarcoma in AIDS","volume":"31","author":"Flaitz","year":"1995","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"ref2781","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2147\/CCID.S94320","article-title":"Chronic radiation-induced dermatitis: challenges and solutions","volume":"9","author":"Spa\u0142ek","year":"2016","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival","volume":"360","author":"Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/QAD.0b013e32835b0fa2","article-title":"Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance","volume":"27","author":"Schwarcz","year":"2013","journal-title":"AIDS"},{"key":"ref2261","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/RLU.0b013e3181813047","article-title":"PET\/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads","volume":"33","author":"Goshen","year":"2008","journal-title":"Clin Nucl Med"},{"key":"ref1911","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study","volume":"24","author":"Buchacz","year":"2010","journal-title":"AIDS"},{"key":"ref2951","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000421-200104000-00016","article-title":"Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index","volume":"24","author":"Sprinz","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"ref3131","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6890-8-7","article-title":"Pathology of rituximab-induced Kaposi sarcoma flare","volume":"8","author":"Pantanowitz","year":"2008","journal-title":"BMC Clin Pathol"},{"key":"ref2281","doi-asserted-by":"crossref","DOI":"10.5070\/D3236035374","article-title":"Cutaneous HIV-associated Kaposi sarcoma: a potential setting for management by clinical observation","volume":"23","author":"Beatrous","year":"2017","journal-title":"Dermatol Online J"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cid\/ciu174","article-title":"Management of HIV infection in patients with cancer receiving chemotherapy","volume":"59","author":"Torres","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/RMR.0000000000000031","article-title":"Imaging of the brain in patients with human immunodeficiency virus infection","volume":"23","author":"Gottumukkala","year":"2014","journal-title":"Top Magn Reson Imaging"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s10461-008-9449-2","article-title":"Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation","volume":"14","author":"Tesoriero","year":"2010","journal-title":"AIDS Behav"},{"key":"ref3081","first-page":"124","article-title":"Treatment of Kaposi s Sarcoma with nab paclitaxel suppl iv Available at https org","volume":"27","author":"FortinoS","year":"2016","journal-title":"Ann Oncol"},{"key":"ref2601","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0385-8146(00)00053-5","article-title":"Local treatment of AIDS-associated bulky Kaposi\u2019s sarcoma in the head and neck region","volume":"27","author":"Shimomura","year":"2000","journal-title":"Auris Nasus Larynx"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/000348949610500405","article-title":"Intralesional vinblastine for treating AIDS-associated Kaposi\u2019s sarcoma of the oropharynx and larynx","volume":"105","author":"Friedman","year":"1996","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref2071","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-associated cancers and related diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N Engl J Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"ref2911","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1200\/JCO.2016.69.3812","article-title":"Pomalidomide for symptomatic Kaposi\u2019s sarcoma in people with and without HIV infection: a phase I\/II study","volume":"34","author":"Polizzotto","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JOP.2015.005116","article-title":"HIV testing in patients with cancer at the initiation of therapy at a large US comprehensive cancer center","volume":"11","author":"Hwang","year":"2015","journal-title":"J Oncol Pract"},{"key":"ref2361","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/QAD.0000000000000993","article-title":"Steroids are a risk factor for Kaposi\u2019s sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection","volume":"30","author":"Fern\u00e1ndez-S\u00e1nchez","year":"2016","journal-title":"AIDS"},{"key":"ref1961","doi-asserted-by":"crossref","first-page":"440","DOI":"10.6004\/jnccn.2003.0038","article-title":"Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trials","volume":"1","author":"Dale","year":"2003","journal-title":"J Natl Compr Canc Netw"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2340\/00015555-0850","article-title":"Imiquimod for the treatment of classical Kaposi\u2019s sarcoma","volume":"90","author":"Bernardini","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"ref2441","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D302V86610","article-title":"Off-label indications for imiquimod","volume":"15","author":"Ganjian","year":"2009","journal-title":"Dermatol Online J"},{"key":"ref2371","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/QAI.0b013e3181bc476f","article-title":"Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study","volume":"53","author":"Letang","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref1301","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/cncr.25362","article-title":"Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy","volume":"116","author":"Cianfrocca","year":"2010","journal-title":"Cancer"},{"key":"ref2091","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/modpathol.2008.15","article-title":"Classic Kaposi Sarcoma in the United States over the last two decades: a clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi Sarcoma","volume":"21","author":"Hiatt","year":"2008","journal-title":"Mod Pathol"},{"key":"ref1721","first-page":"1993","article-title":"Increased incidence of cancer observed in HIV HCV coinfected patients versus HIV - monoinfected Available at https www ncbi nlm nih gov pubmed Accessed","volume":"14","author":"MeijideH","year":"2017","journal-title":"AIDS"},{"key":"ref1971","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.bmt.1701610","article-title":"Neutropenic infections in 100 patients with non-Hodgkin\u2019s lymphoma or Hodgkin\u2019s disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option","volume":"23","author":"Seropian","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"ref2561","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1368-8375(01)00100-2","article-title":"Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi\u2019s sarcoma. A double blind, randomized clinical trial","volume":"38","author":"Ram\u00edrez-Amador","year":"2002","journal-title":"Oral Oncol"},{"key":"ref1331","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/annonc\/mdg461","article-title":"Paclitaxel for anthracycline-resistant AIDS-related Kaposi\u2019s sarcoma: clinical and angiogenic correlations","volume":"14","author":"Stebbing","year":"2003","journal-title":"Ann Oncol"},{"key":"ref2311","first-page":"44","article-title":"Acquired immunodeficiency syndrome-related Kaposi\u2019s sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome","volume":"28","author":"Cattelan","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2310\/7750.2011.10039","article-title":"Kaposi sarcoma of the penis in an HIV-negative patient","volume":"15","author":"Cecchi","year":"2011","journal-title":"J Cutan Med Surg"},{"key":"ref611","first-page":"163","article-title":"Cutaneous cryptococcosis simulating Kaposi\u2019s sarcoma in the acquired immunodeficiency syndrome","volume":"45","author":"Jones","year":"1990","journal-title":"Cutis"},{"key":"ref2931","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2011.39.6853","article-title":"Phase II study of bevacizumab in patients with HIV-associated Kaposi\u2019s sarcoma receiving antiretroviral therapy","volume":"30","author":"Uldrick","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref1681","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1054-3589(07)56016-3","article-title":"The viral etiology of AIDS-associated malignancies","volume":"56","author":"Angeletti","year":"2008","journal-title":"Adv Pharmacol"},{"key":"ref1981","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","article-title":"Biphasic pattern of bacterial infection in multiple myeloma","volume":"96","author":"Savage","year":"1982","journal-title":"Ann Intern Med"},{"key":"ref2791","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi\u2019s sarcoma: results of a randomized phase III clinical trial","volume":"16","author":"Northfelt","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"e0182750","DOI":"10.1371\/journal.pone.0182750","article-title":"Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013","volume":"12","author":"Royse","year":"2017","journal-title":"PLoS One"},{"key":"ref1411","first-page":"1","article-title":"Randomized phase IIA trial of gemcitabine compared with bleomycin plus vincristine for treatment of Kaposi\u2019s sarcoma in patients on combination antiretroviral therapy in Western Kenya","volume":"4","author":"Busakhala","year":"2018","journal-title":"J Glob Oncol"},{"key":"ref1711","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study","volume":"4","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Lancet HIV"},{"key":"ref2021","first-page":"13","article-title":"Empiric antibiotic therapy for granulocytopenic cancer patients","volume":"80","author":"Schimpff","year":"1986","journal-title":"Am J Med"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00126334-199911010-00004","article-title":"Treatment of AIDS-related cutaneous Kaposi\u2019s sarcoma with topical alitretinoin (9-cis-retinoic acid) gel","volume":"22","author":"Walmsley","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2401","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/QAD.0b013e3282f4f223","article-title":"Life-threatening exacerbation of Kaposi\u2019s sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome","volume":"22","author":"Volkow","year":"2008","journal-title":"AIDS"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0956462413517494","article-title":"Isolated penile Kaposi\u2019s sarcoma in a HIV-positive patient stable on treatment for three years","volume":"25","author":"Lebari","year":"2014","journal-title":"Int J STD AIDS"},{"key":"ref2231","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1750-3639.2003.tb00019.x","article-title":"Changing patterns in the neuropathogenesis of HIV during the HAART era","volume":"13","author":"Langford","year":"2003","journal-title":"Brain Pathol"},{"key":"ref3091","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2000.18.13.2593","article-title":"Activity of thalidomide in AIDS-related Kaposi\u2019s sarcoma","volume":"18","author":"Little","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref2391","first-page":"727","article-title":"AIDS-related Kaposi\u2019s sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation","volume":"146","author":"Guo","year":"1995","journal-title":"Am J Pathol"},{"key":"ref2121","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S0950268812000325","article-title":"Epidemiology of classic and AIDS-related Kaposi\u2019s sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005","volume":"141","author":"Armstrong","year":"2013","journal-title":"Epidemiol Infect"},{"key":"ref2471","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2340\/00015555-0850","article-title":"Imiquimod for the treatment of classical Kaposi\u2019s sarcoma","volume":"90","author":"Bernardini","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"ref2991","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.3747\/co.22.2635","article-title":"Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control: a case report and literature review","volume":"22","author":"Cao","year":"2015","journal-title":"Curr Oncol"},{"key":"ref2731","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-8140(97)00147-3","article-title":"Radiotherapy in the management of epidemic Kaposi\u2019s sarcoma: a retrospective study of 643 cases","volume":"46","author":"Kirova","year":"1998","journal-title":"Radiother Oncol"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/infdis\/jiv235","article-title":"Mortality risk after AIDS-defining opportunistic illness among HIV-infected persons\u2013San Francisco, 1981-2012","volume":"212","author":"Djawe","year":"2015","journal-title":"J Infect Dis"},{"key":"ref1991","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2249.1992.tb06965.x","article-title":"Predictors of infection in chronic lymphocytic leukaemia (CLL)","volume":"89","author":"Griffiths","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"ref1901","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cid\/ciu174","article-title":"Management of HIV infection in patients with cancer receiving chemotherapy","volume":"59","author":"Torres","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref2061","doi-asserted-by":"crossref","first-page":"2138259","DOI":"10.1155\/2016\/2138259","article-title":"Risk of cancer among commercially insured HIV-infected adults on antiretroviral therapy","volume":"2016","author":"Lee","year":"2016","journal-title":"J Cancer Epidemiol"},{"key":"ref1871","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.2011.396","article-title":"Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007","volume":"305","author":"Shiels","year":"2011","journal-title":"JAMA"},{"key":"ref2321","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00002030-200005260-00010","article-title":"Long-term efficacy on Kaposi\u2019s sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d\u2019information et de soins de l\u2019immunod\u00e9ficience humaine","volume":"14","author":"Dupont","year":"2000","journal-title":"AIDS"},{"key":"ref1101","first-page":"107","article-title":"A rare case of Kaposi\u2019s sarcoma; hand localization","volume":"22","author":"Ozbek","year":"1990","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"ref1561","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6890-8-7","article-title":"Pathology of rituximab-induced Kaposi sarcoma flare","volume":"8","author":"Pantanowitz","year":"2008","journal-title":"BMC Clin Pathol"},{"key":"ref741","first-page":"44","article-title":"Acquired immunodeficiency syndrome-related Kaposi\u2019s sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome","volume":"28","author":"Cattelan","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref1451","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1258\/0956462991914285","article-title":"A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi\u2019s sarcoma. Swiss HIV Cohort Study","volume":"10","author":"Opravil","year":"1999","journal-title":"Int J STD AIDS"},{"key":"ref1931","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/QAD.0b013e32835b0fa2","article-title":"Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance","volume":"27","author":"Schwarcz","year":"2013","journal-title":"AIDS"},{"key":"ref1801","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.2010.752","article-title":"Time for oncologists to opt in for routine opt-out HIV testing?","volume":"304","author":"Chiao","year":"2010","journal-title":"JAMA"},{"key":"ref2041","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jnci\/89.4.301","article-title":"Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma treated with chemotherapy","volume":"89","author":"Sparano","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"ref711","doi-asserted-by":"crossref","DOI":"10.5070\/D3236035374","article-title":"Cutaneous HIV-associated Kaposi sarcoma: a potential setting for management by clinical observation","volume":"23","author":"Beatrous","year":"2017","journal-title":"Dermatol Online J"},{"key":"ref2201","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/1817-1737.69106","article-title":"Imaging lung manifestations of HIV\/AIDS","volume":"5","author":"Allen","year":"2010","journal-title":"Ann Thorac Med"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/RLU.0b013e3181813047","article-title":"PET\/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads","volume":"33","author":"Goshen","year":"2008","journal-title":"Clin Nucl Med"},{"key":"ref2101","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/QAD.0000000000000682","article-title":"Epidemiology of Kaposi\u2019s sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy","volume":"29","author":"Labo","year":"2015","journal-title":"AIDS"},{"key":"ref821","first-page":"727","article-title":"AIDS-related Kaposi\u2019s sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation","volume":"146","author":"Guo","year":"1995","journal-title":"Am J Pathol"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1750-3639.2003.tb00019.x","article-title":"Changing patterns in the neuropathogenesis of HIV during the HAART era","volume":"13","author":"Langford","year":"2003","journal-title":"Brain Pathol"},{"key":"ref2941","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1200\/JCO.1997.15.5.2118","article-title":"Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi\u2019s sarcoma with no prior exposure to cytotoxic therapy","volume":"15","author":"Schwartsmann","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref2961","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1200\/JCO.2002.12.038","article-title":"Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi\u2019s sarcoma: an AIDS Clinical Trials Group clinical study","volume":"20","author":"Evans","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1200\/JCO.1987.5.1.107","article-title":"The impact of palliative irradiation on the management of patients with acquired immune deficiency syndrome","volume":"5","author":"Nobler","year":"1987","journal-title":"J Clin Oncol"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2230.2011.04278.x","article-title":"Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation","volume":"37","author":"Prinz Vavricka","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"ref1441","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1200\/JCO.2012.48.6365","article-title":"Phase II trial of imatinib in AIDS-associated Kaposi\u2019s sarcoma: AIDS Malignancy Consortium Protocol 042","volume":"32","author":"Koon","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref2871","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/cncr.25362","article-title":"Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy","volume":"116","author":"Cianfrocca","year":"2010","journal-title":"Cancer"},{"key":"ref2761","doi-asserted-by":"crossref","first-page":"298","DOI":"10.21037\/apm.2016.08.03","article-title":"Radiation therapy for the treatment of skin Kaposi sarcoma","volume":"5","author":"Tsao","year":"2016","journal-title":"Ann Palliat Med"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"298","DOI":"10.21037\/apm.2016.08.03","article-title":"Radiation therapy for the treatment of skin Kaposi sarcoma","volume":"5","author":"Tsao","year":"2016","journal-title":"Ann Palliat Med"},{"key":"ref2461","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.4076\/1757-1626-2-7092","article-title":"Kaposi\u2019s sarcoma responding to topical imiquimod 5% cream: a case report","volume":"2","author":"Benomar","year":"2009","journal-title":"Cases J"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/1817-1737.69106","article-title":"Imaging lung manifestations of HIV\/AIDS","volume":"5","author":"Allen","year":"2010","journal-title":"Ann Thorac Med"},{"key":"ref2611","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0190-9622(93)70010-Q","article-title":"Intralesional vinblastine for cutaneous Kaposi\u2019s sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection","volume":"28","author":"Boudreaux","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1093\/cid\/ciu592","article-title":"Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies","volume":"59","author":"Morrison","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref2411","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00128071-200102020-00004","article-title":"Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi\u2019s sarcoma","volume":"2","author":"Bodsworth","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"ref2451","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-3062.2007.00239.x","article-title":"Development of Kaposi\u2019s sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod","volume":"10","author":"Babel","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0190-9622(93)70010-Q","article-title":"Intralesional vinblastine for cutaneous Kaposi\u2019s sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection","volume":"28","author":"Boudreaux","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"ref2331","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/QAD.0b013e3282ff6275","article-title":"Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response","volume":"22","author":"Nguyen","year":"2008","journal-title":"AIDS"},{"key":"ref1881","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/aje\/kwm017","article-title":"The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS","volume":"165","author":"Hessol","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.2010.752","article-title":"Time for oncologists to opt in for routine opt-out HIV testing?","volume":"304","author":"Chiao","year":"2010","journal-title":"JAMA"},{"key":"ref1281","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1998.16.3.1112","article-title":"Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi\u2019s sarcoma","volume":"16","author":"Welles","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1054-3589(07)56016-3","article-title":"The viral etiology of AIDS-associated malignancies","volume":"56","author":"Angeletti","year":"2008","journal-title":"Adv Pharmacol"},{"key":"ref1591","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDS-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref2981","first-page":"1","article-title":"Randomized phase IIA trial of gemcitabine compared with bleomycin plus vincristine for treatment of Kaposi\u2019s sarcoma in patients on combination antiretroviral therapy in Western Kenya","volume":"4","author":"Busakhala","year":"2018","journal-title":"J Glob Oncol"},{"key":"ref3001","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1200\/JCO.2005.06.079","article-title":"Imatinib-induced regression of AIDS-related Kaposi\u2019s sarcoma","volume":"23","author":"Koon","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref2141","doi-asserted-by":"crossref","first-page":"e0182750","DOI":"10.1371\/journal.pone.0182750","article-title":"Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013","volume":"12","author":"Royse","year":"2017","journal-title":"PLoS One"},{"key":"ref1501","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.qai.0000194237.15831.23","article-title":"Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial","volume":"41","author":"Krown","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/QAI.0b013e3181bc476f","article-title":"Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study","volume":"53","author":"Letang","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref1551","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJMe058018","article-title":"Immunosuppressive drugs and the risk of cancer after organ transplantation","volume":"352","author":"Dantal","year":"2005","journal-title":"N Engl J Med"},{"key":"ref1631","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"ref2341","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/QAI.0b013e318251aedd","article-title":"A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa","volume":"60","author":"Mosam","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/ciu783","article-title":"Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program","volume":"60","author":"Irvine","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-associated cancers and related diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N Engl J Med"},{"key":"ref1511","first-page":"124","article-title":"Treatment of Kaposi s Sarcoma with nab paclitaxel suppl iv Available at https org","volume":"27","author":"FortinoS","year":"2016","journal-title":"Ann Oncol"},{"key":"ref1851","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/ciu783","article-title":"Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program","volume":"60","author":"Irvine","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref2051","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"key":"ref2521","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-4632.2006.02829.x","article-title":"Limited extent AIDS-related cutaneous Kaposi\u2019s sarcoma responsive to imiquimod 5% cream","volume":"45","author":"Rosen","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"DJU503","DOI":"10.1093\/jnci\/dju503","article-title":"Excess cancers among HIV-infected people in the United States","volume":"107","author":"Robbins","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10461-015-1025-y","article-title":"Alcohol-related diagnoses and all-cause hospitalization among HIV-infected and uninfected patients: a longitudinal analysis of United States veterans from 1997 to 2011","volume":"20","author":"Rentsch","year":"2016","journal-title":"AIDS Behav"},{"key":"ref1811","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JOP.2015.005116","article-title":"HIV testing in patients with cancer at the initiation of therapy at a large US comprehensive cancer center","volume":"11","author":"Hwang","year":"2015","journal-title":"J Oncol Pract"},{"key":"ref1381","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000421-200104000-00016","article-title":"Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index","volume":"24","author":"Sprinz","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"ref2111","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/QAI.0000000000001394","article-title":"Association of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada","volume":"75","author":"Dubrow","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(03)14366-8","article-title":"Whole-body positron emission tomography in patients with HIV-1 infection","volume":"362","author":"Scharko","year":"2003","journal-title":"Lancet"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/17\/2\/article-p171.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T19:35:16Z","timestamp":1720985716000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/17\/2\/article-p171.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":308,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2019.0008","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}